Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Changes in the Gut Microbiome Associated with Intussusception in Patients with Peutz-Jeghers Syndrome. | Microbiol Spectr | 2023 | 36719190 | PubTator, text mining | PubMed |
| Factor XI inhibitors: what should clinicians know. | Curr Opin Cardiol | 2023 | 36718618 | PubTator, text mining | PubMed |
| Prediction of venous thromboembolism incidence in the general adult population using two published genetic risk scores. | PLoS One | 2023 | 36716319 | PubTator, text mining | PubMed |
| Synthesis of Carbon Dots with Hemostatic Effects Using Traditional Chinese Medicine as a Biomass Carbon Source. | ACS Omega | 2023 | 36713698 | PubTator, text mining | PubMed |
| "iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives". | Front Physiol | 2023 | 36711019 | PubTator, text mining | PubMed |
| 6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors. | Cardiovasc Hematol Agents Med Chem | 2023 | 36703578 | PubTator, text mining | PubMed |
| Titanium is a potent inducer of contact activation: implications for intravascular devices. | J Thromb Haemost | 2023 | 36696212 | PubTator, text mining | PubMed |
| Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency. | J Thromb Haemost | 2023 | 36696199 | PubTator, text mining | PubMed |
| Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease. | J Thromb Haemost | 2023 | 36696180 | PubTator, text mining | PubMed |
| Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombin. | J Thromb Haemost | 2023 | 36695400 | PubTator, text mining | PubMed |
| Staphylococcus aureus sequence type (ST) 45, ST30, and ST15 in the gut microbiota of healthy infants - persistence and population counts in relation to ST and virulence gene carriage. | Eur J Clin Microbiol Infect Dis | 2023 | 36689019 | PubTator, text mining | PubMed |
| A Cortisol-Secreting Adrenal Adenoma Combined With a Micro-Pheochromocytoma: Case Report and Literature Review. | Clin Med Insights Endocrinol Diabetes | 2023 | 36685045 | PubTator, text mining | PubMed |
| Novel Antioxidant Peptides from Pearl Shell Meat Hydrolysate and Their Antioxidant Activity Mechanism. | Molecules | 2023 | 36677922 | PubTator, text mining | PubMed |
| Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19. | J Clin Med | 2023 | 36675530 | PubTator, text mining | PubMed |
| Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. | Cardiovasc Res | 2023 | 36662542 | PubTator, text mining | PubMed |
| The Impact of Acute Nutritional Interventions on the Plasma Proteome. | J Clin Endocrinol Metab | 2023 | 36658456 | PubTator, text mining | PubMed |
| Desmopressin as a hemostatic and blood sparing agent in bleeding disorders. | Eur J Haematol | 2023 | 36656570 | PubTator, text mining | PubMed |
| 3-(1H-Imidazol-2-Yl)-2,3,8,8a-Tetrahydroindolizin-5(1H)-One Derivatives are Useful as Factor Xia Inhibitors and Their Preparation. | Cardiovasc Hematol Agents Med Chem | 2023 | 36654472 | PubTator, text mining | PubMed |
| How I approach bleeding in hospitalized patients. | Blood | 2023 | 36652635 | PubTator, text mining | PubMed |
| Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg- Calvé-Perthes Disease. | Clin Appl Thromb Hemost | 2023 | 36650707 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=27